CCommittee for Medicinal Products for Human Use· Health · 11 sources · Oct 16, 2026StoryEU Panel Recommends Lilly’s Foundayo Weight-Loss PillEMA's CHMP on Oct. 16, 2026, backed Eli Lilly's once-daily Foundayo pill for weight loss and type 2 diabetes; a European Commission decision usually follows in about two months.Health· Oct 16, 2026+8+12ShareNicole Hardy·Oct 16, 2026Top commentI worry about long-term side effects though, even if the panel backed it for now.ReplyGenius replyShareWrite a comment…